Home > Annual Financials > TTK HEALTHCARE

TTK HEALTHCARE Financial Statement Analysis
[BOM: 507747|NSE : TTKHLTCARE]

The Revenues of TTK HEALTHCARE have increased by 6.47% YoY .
The Earnings Per Share (EPS) of TTK HEALTHCARE has increased by 29.95 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

TTK HEALTHCARE Last 5 Annual Financial Results
[BOM: 507747|NSE : TTKHLTCARE]

StandaloneMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹801 Cr₹753 Cr₹725 Cr₹599 Cr₹476 Cr
Expenses ₹767 Cr₹715 Cr₹694 Cr₹577 Cr₹457 Cr
Operating Profit (Excl OI) ₹35 Cr₹37 Cr₹31 Cr₹22 Cr₹19 Cr
Other Income ₹71 Cr₹63 Cr₹48 Cr₹16 Cr₹9.94 Cr
Interest ₹3.32 Cr₹2.76 Cr₹5.24 Cr₹3.24 Cr₹1.71 Cr
Depreciation ₹8.33 Cr₹13 Cr₹13 Cr₹13 Cr₹13 Cr
Profit Before Tax ₹108 Cr₹84 Cr₹62 Cr₹25 Cr₹23 Cr
Profit After Tax ₹82 Cr₹63 Cr₹45 Cr₹19 Cr₹37 Cr
Earnings Per Share (Rs)₹57.79₹44.47₹31.61₹13.10₹26.03
PAT Margin (%)9.897.945.943.097.73
ROE(%)7.946.467.016.0213.76
ROCE(%)10.638.7210.138.598.38
Total Debt/Equity(x)0.020.020.030.060.06

Key Financials

Market Cap : ₹ 1,824.6 Cr
Revenue (TTM) : ₹ 801.5 Cr
Net Profit(TTM) : ₹ 81.7 Cr
EPS (TTM) : ₹ 57.9
P/E (TTM) : 22.3

Industry Peers & Returns1W1M1Y
TTK HEALTHCARE -4.5% -1% -11.6%
SUN PHARMACEUTICAL INDUSTRIES -0.7% -1.3% 6.6%
DIVIS LABORATORIES 1.8% 4.8% 49.8%
CIPLA -1.1% -1.3% -1.4%
TORRENT PHARMACEUTICALS 0.6% 4.2% 15.1%
DR REDDYS LABORATORIES -1.8% -6% -1.6%
MANKIND PHARMA 6.9% 6.2% 13.7%
ZYDUS LIFESCIENCES -2.1% -0.3% -15.4%
LUPIN -2.2% -4.7% 8.6%


TTK HEALTHCARE Revenues
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

6.47 %

5 Yr CAGR

13.91 %

Years Revenues % Change
Mar2025 ₹801 Cr
6.47
Mar2024 ₹753 Cr
3.82
Mar2023 ₹725 Cr
21.00
Mar2022 ₹599 Cr
25.88
Mar2021 ₹476 Cr -


TTK HEALTHCARE Operating Profit
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

-6.69 %

5 Yr CAGR

15.87 %

Years Operating Profit % Change
Mar2025 ₹35 Cr
-6.69
Mar2024 ₹37 Cr
19.07
Mar2023 ₹31 Cr
43.56
Mar2022 ₹22 Cr
13.03
Mar2021 ₹19 Cr -

Operating Margins
Y-o-Y

-12.30 %

5 Yr CAGR

1.74 %

Years Operating Margin% % Change
Mar2025 4.35%
-12.30
Mar2024 4.96%
14.81
Mar2023 4.32%
18.68
Mar2022 3.64%
-10.34
Mar2021 4.06% -

TTK HEALTHCARE Profit After Tax
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

29.94 %

5 Yr CAGR

22.06 %

Years Profit After Tax % Change
Mar2025 ₹82 Cr
29.94
Mar2024 ₹63 Cr
40.69
Mar2023 ₹45 Cr
141.32
Mar2022 ₹19 Cr
-49.68
Mar2021 ₹37 Cr -

PAT Margins
Y-o-Y

24.56 %

5 Yr CAGR

6.35 %

Years PAT Margin(%) % Change
Mar2025 9.89 %
24.56
Mar2024 7.94 %
33.67
Mar2023 5.94 %
92.23
Mar2022 3.09 %
-60.03
Mar2021 7.73 % -

TTK HEALTHCARE Earnings Per Share (EPS)
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

29.95 %

5 Yr CAGR

22.07 %

Years EPS % Change
Mar2025 ₹58
29.95
Mar2024 ₹44
40.68
Mar2023 ₹32
141.30
Mar2022 ₹13
-49.67
Mar2021 ₹26 -

TTK HEALTHCARE Return on Capital Employed (ROCE)
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

21.90 %

5 Yr CAGR

6.13 %

Years ROCE % Change
Mar2025 10.63%
21.90
Mar2024 8.72%
-13.92
Mar2023 10.13%
17.93
Mar2022 8.59%
2.51
Mar2021 8.38% -

TTK HEALTHCARE Share Price vs Sensex

Current Share Price : ₹1,294.1
Current MarketCap: ₹ 1,824.6 Cr
Updated EOD on :Jul 09,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-4.5%

-1%

-11.6%

SENSEX

0.2%

1.3%

4.4%

TTK HEALTHCARE related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE SMALLCAP 0.6% 1.4% 1.9%
BSE INDUSTRIALS NA -0.3% -6.3%
No NSE index found

You may also like the below Video Courses


FAQ about TTK HEALTHCARE Financials


How the annual revenues of TTK HEALTHCARE have changed ?

The Revenues of TTK HEALTHCARE have increased by 6.47% YoY .

How the Earnings per Share (EPS) of TTK HEALTHCARE have changed?

The Earnings Per Share (EPS) of TTK HEALTHCARE has increased by 29.95 % YoY .